Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

FDA "disease" definition for supplements threatens structure/function claims -- CRN.

This article was originally published in The Tan Sheet

Executive Summary

FDA "DISEASE" DEFINITION FOR SUPPLEMENT CLAIMS COULD "CONSUME" STRUCTURE/FUNCTION category, the Council for Responsible Nutrition says, rendering the classification of permissible dietary supplement statements "meaningless." In Aug. 11 comments to FDA, CRN urges the agency to withdraw the revised definition of "disease" set forth in its April 29 proposed rule delineating acceptable structure/function claims. CRN maintains it is "opposed to expansion of the disease definition, and in particular, to the inclusion of the phrase `structure or function' in the definition."

You may also be interested in...



FDA Should Adopt FTC` Regulatory Policy For Supplement Claims, CRN Says

FDA should emulate the Federal Trade Commission and focus on ensuring dietary supplements make truthful and substantiated label statements instead of worrying about what constitutes an implied disease claim, Council for Responsible Nutrition Scientific and Regulatory Affairs VP Annette Dickinson, PhD, commented at an FDA meeting on structure/function claims in Washington, D.C. Aug. 4.

FDA Should Adopt FTC` Regulatory Policy For Supplement Claims, CRN Says

FDA should emulate the Federal Trade Commission and focus on ensuring dietary supplements make truthful and substantiated label statements instead of worrying about what constitutes an implied disease claim, Council for Responsible Nutrition Scientific and Regulatory Affairs VP Annette Dickinson, PhD, commented at an FDA meeting on structure/function claims in Washington, D.C. Aug. 4.

FDA Should Adopt FTC` Regulatory Policy For Supplement Claims, CRN Says

FDA should emulate the Federal Trade Commission and focus on ensuring dietary supplements make truthful and substantiated label statements instead of worrying about what constitutes an implied disease claim, Council for Responsible Nutrition Scientific and Regulatory Affairs VP Annette Dickinson, PhD, commented at an FDA meeting on structure/function claims in Washington, D.C. Aug. 4.

Topics

UsernamePublicRestriction

Register

OM017181

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel